Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

ClinicalTrials.gov ID: NCT05696392

Public ClinicalTrials.gov record NCT05696392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 6:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Single-Arm, Phase 4 Study of Ruxolitinib Cream in Adults With Atopic Dermatitis Experiencing Sleep Disturbance in the United States (MORPHEUS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis.

Study identification

NCT ID
NCT05696392
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Incyte Corporation
Industry
Enrollment
47 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2023
Primary completion
Jan 21, 2025
Completion
Jan 21, 2025
Last update posted
Dec 18, 2025

2023 – 2025

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
First Oc Dermatology Fountain Valley California 92708
Ark Clinical Research Long Beach California 90815
Gw Training Center Washington D.C. District of Columbia 20037
Skin Care Research, Llc Boca Raton Florida 33486
Driven Research Llc Coral Gables Florida 33134
University of Florida Health Dermatology-Springhill Gainesville Florida 32606
Skin Care Research, Llc Scr Hollywood Hollywood Florida 33021
Ciocca Dermatology Pa Miami Florida 33173
Trueblue Clinical Research Tampa Florida 33609
Dermatology Specialists Research Indiana Clarksville Indiana 47129
Dawes Fretzin Clinical Research Group Llc Indianapolis Indiana 46250
Skin Sciences Pllc Louisville Kentucky 40217
Beth Israel Deaconess Medical Center (Bidmc) Boston Massachusetts 02215
Northeast Dermatology Associates Methuen Massachusetts 01844
Essential Dermatology Natick Massachusetts 01760
Washington University School of Medicine Dermatology St Louis Missouri 63110
Suny Downstate Health Sciences University Brooklyn New York 11203
Empire Dermatology East Syracuse New York 13057
Sadick Dermatology New York New York 10075
Skin Search of Rochester Rochester New York 14623
Ohio Pediatric Research Association Dayton Ohio 45414
Oregon Dermatology and Research Center Portland Oregon 97210
Knight Cancer Institute At Oregon Health and Science University Portland Oregon 97239
University of Pittsburgh Pittsburgh Pennsylvania 15213
Clinical Research Center of the Carolinas Charleston South Carolina 29407
Arlington Research Center Arlington Texas 76011
Jordan Valley Dermatology Center South Jordan Utah 84095
Pi Coor Clinical Research Llc Burke Virginia 22015
Clinical Research Partners Llc Richmond Virginia 23226
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05696392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2025 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05696392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →